BioLine RX Ltd
Change company Symbol lookup
Select an option...
BLRX BioLine RX Ltd
BLPH Bellerophon Therapeutics Inc
BLNK Blink Charging Co
CTXS Citrix Systems Inc
AFHIF Atlas Financial Holdings Inc
RIOCF RioCan Real Estate Investment Trust
OMP Oasis Midstream Partners LP
GMED Globus Medical Inc
TSN Tyson Foods Inc
VOO Vanguard S&P 500 ETF
Go

Health Care : Biotechnology | Small Cap Value
Based in Israel
Company profile

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Premarket

Last Trade
Delayed
$2.77
-0.18 (-6.10%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.95
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
82

10-day average volume:
1,283,936
82

UPDATE: Airline stocks rally, led by American Airlines, after Deutsche Bank's sector-wide upgrade to buy

7:44 am ET February 22, 2021 (MarketWatch)
Print

Airline stocks are set up for a broad rally, led by American Airlines Group Inc. (AAL) shares, after Deutsche Bank analyst Michael Linenberg said it was time to buy into the sector as COVID-19 cases, hospitalizations and vaccination rates are all trending in the right direction. He upgraded nine U.S.-based airlines to buy from hold. "As our upgrade is a sector-wide call, we are of the view that all of our names could see material upside from current levels," Linenberg wrote in a note to clients. Among the biggest premarket gainers, shares of American Airlines shot up 5.8%, JetBlue Airways Corp. (JBLU) rallied 2.1%, Delta Air Lines Inc. (DAL) rose 1.6%, Southwest Airlines Co. (LU) hiked up 1.3% and Alaska Air Group Inc. (ALK) tacked on 1.2%. Meanwhile, United Airlines Holdings Inc. (UAL) edged up 0.3%, after an engine on Flight 328 blew apart midflight (http://www.marketwatch.com/story/faa-orders-boeing-777-inspections-after-engine-blows-over-denver-suburb-01613959007) on Saturday. The U.S. Global Jets ETF (JETS) climbed 1.4% ahead of the open, putting it on track to open at a one-year high, while futures for the S&P 500 fell 0.8%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

February 22, 2021 07:44 ET (12:44 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.